SCHEMBL16405115

SCHEMBL16405115

Brc1nc([C@@H]2CCCN2)[nH]c1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN10A Q9Y5Y9 1/20 0.41
▸ CDC7 O00311 6/20 0.40
▸ PIM1 P11309 3/20 0.40
▸ CSNK2B P67870 3/20 0.40
▸ CSNK2A1 P68400 3/20 0.40
▸ PARP1 P09874 5/20 0.40
▸ CCNE1 P24864 3/20 0.36
▸ CDK2 P24941 3/20 0.36
▸ ROCK1 Q13464 3/20 0.36
▸ DBF4 Q9UBU7 3/20 0.36
▸ DYRK1A Q13627 2/20 0.35
▸ CIT O14578 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CSNK2A2 P19784 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ CSNK2A3 Q8NEV1 1/20 0.35
▸ TAOK3 Q9H2K8 1/20 0.35
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA7 P36544 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16405084 1.00 SCN10A (0.41) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL20018386 0.86 PARP1 (0.36) CDC7PARP1CCNE1CDK2ROCK1
SCHEMBL20018277 0.82 SCN10A (0.40) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL1494644 0.72 KDM4E (0.35) CYP1A2
SCHEMBL12294943 0.72 KDM4E (0.39) CYP1A2
SCHEMBL1494613 0.71 POLB (0.35) —
SCHEMBL18870909 0.70 SCN10A (0.44) SCN10ACDC7PIM1CSNK2BCSNK2A1
SCHEMBL18815648 0.70 SCN10A (0.44) SCN10ACDC7PARP1CCNE1CDK2
SCHEMBL18815650 0.70 SCN10A (0.44) SCN10ACDC7PARP1CCNE1CDK2
SCHEMBL17929014 0.69 SCN10A (0.38) SCN10ACDC7PIM1CSNK2BCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2685984-B1 TETRACYCLIC XANTHENE DERIVATIVES AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2016-11-02 — — EP disclosed
EP-2545060-B1 FUSED TRICYCLIC SILYL COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES MERCK SHARP & DOHME (US) 2015-11-25 — — EP disclosed
EP-2435424-B1 ANTIVIRAL COMPOUNDS COMPOSED OF THREE LINKED ARYL MOIETIES TO TREAT DISEASES SUCH AS HEPATITIS C MERCK SHARP & DOHME (US) 2015-01-21 — — EP disclosed
Send feedback